Michael Walker, global lead for healthcare in Oracle’s Industry Solutions group, wrote in Forbes about how a patient-centered supply chain plays a crucial role in the future of healthcare.

Throughout cancer treatments, one question that often comes up is, “Is there a clinical trial that I should consider for my treatment?” Since there are tens of thousands of clinical trials throughout the world, it can be difficult to know if a patient is a good fit for a trial or if it will work out logistically. Chris Murphy, Director of Cloud Content at Oracle, wrote an article in Forbes about how AI and a chatbot can help patients and doctors can work together to decide if an experimental treatment is the right fit and if a patient is eligible for a clinical trial.

Throughout cancer treatments, one question that often comes up is, “Is there a clinical trial that I should consider for my treatment?” Since there are tens of thousands of clinical trials throughout the world, it can be difficult to know if a patient is a good fit for a trial or if it will work out logistically. Chris Murphy, Director of Cloud Content at Oracle, wrote an article in Forbes about how AI and a chatbot can help patients and doctors can work together to decide if an experimental treatment is the right fit and if a patient is eligible for a clinical trial.

Throughout cancer treatments, one question that often comes up is, “Is there a clinical trial that I should consider for my treatment?” Since there are tens of thousands of clinical trials throughout the world, it can be difficult to know if a patient is a good fit for a trial or if it will work out logistically. Chris Murphy, Director of Cloud Content at Oracle, wrote an article in Forbes about how AI and a chatbot can help patients and doctors can work together to decide if an experimental treatment is the right fit and if a patient is eligible for a clinical trial.

Throughout cancer treatments, one question that often comes up is, “Is there a clinical trial that I should consider for my treatment?” Since there are tens of thousands of clinical trials throughout the world, it can be difficult to know if a patient is a good fit for a trial or if it will work out logistically. Chris Murphy, Director of Cloud Content at Oracle, wrote an article in Forbes about how AI and a chatbot can help patients and doctors can work together to decide if an experimental treatment is the right fit and if a patient is eligible for a clinical trial.

Throughout cancer treatments, one question that often comes up is, “Is there a clinical trial that I should consider for my treatment?” Since there are tens of thousands of clinical trials throughout the world, it can be difficult to know if a patient is a good fit for a trial or if it will work out logistically. Chris Murphy, Director of Cloud Content at Oracle, wrote an article in Forbes about how AI and a chatbot can help patients and doctors can work together to decide if an experimental treatment is the right fit and if a patient is eligible for a clinical trial.

Throughout cancer treatments, one question that often comes up is, “Is there a clinical trial that I should consider for my treatment?” Since there are tens of thousands of clinical trials throughout the world, it can be difficult to know if a patient is a good fit for a trial or if it will work out logistically. Chris Murphy, Director of Cloud Content at Oracle, wrote an article in Forbes about how AI and a chatbot can help patients and doctors can work together to decide if an experimental treatment is the right fit and if a patient is eligible for a clinical trial.

Throughout cancer treatments, one question that often comes up is, “Is there a clinical trial that I should consider for my treatment?” Since there are tens of thousands of clinical trials throughout the world, it can be difficult to know if a patient is a good fit for a trial or if it will work out logistically. Chris Murphy, Director of Cloud Content at Oracle, wrote an article in Forbes about how AI and a chatbot can help patients and doctors can work together to decide if an experimental treatment is the right fit and if a patient is eligible for a clinical trial.